nand k roy
La Jolla Institute for Immunology (LJI)
La Jolla, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
La Jolla Institute for Immunology (LJI)
La Jolla, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Institute of Food Sciences, National Research Council (CNR)
Avellino, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
Independent researcher
NGO Praeventio, Tartu, Estonia
Associate Editor
Pharmacology of Anti-Cancer Drugs
Aragonese Institute of Health Research, University of Zaragoza
Zaragoza, Spain
Associate Editor
Pharmacology of Anti-Cancer Drugs
Bharathidasan University
Tiruchirappalli, India
Associate Editor
Pharmacology of Anti-Cancer Drugs
Institute for Biomedical Sciences, Shinshu University
Nagano, Japan
Associate Editor
Pharmacology of Anti-Cancer Drugs
Garrahan Hospital
Buenos Aires, Argentina
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Florida
Gainesville, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
College of Medicine, The Pennsylvania State University
Hershey, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Central University of Punjab
Bathinda, India
Associate Editor
Pharmacology of Anti-Cancer Drugs
Department of Biotechnology, SRM Institute of Science and Technology
Kancheepuram, India
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Liège
Liège, Belgium
Associate Editor
Pharmacology of Anti-Cancer Drugs
Frederick National Laboratory for Cancer Research, National Cancer Institute at Frederick (NIH)
Frederick, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Texas Tech University Health Sciences Center, Abilene
Abilene, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
School of Medicine, Johns Hopkins University
Baltimore, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University
Harbin, China
Associate Editor
Pharmacology of Anti-Cancer Drugs